3 diabetic chronic treatments (40% for both), and 27% were on insulin therapy. The other antidiabetic medications, including glinide, glitazone, and acarbose were rarely used (3%, 2%, and 5%, respectively). Mean baseline and post PCI Cr levels were 102±52 and 122±81μmol/L. Rate of CIN was similar in patients with or without metformin (21 vs 20%, respectively, p= 0.87). Logistic regression for the risk of CIN taking into account classical risk factors showed no impact of chronic metformin therapy, even in stratified analysis in patients with chronic kidney disease. Hospital mortality was similar between groups (7 vs 6%, respectively, p=0.69). Moreover, no case of lactic acidosis was reported during the hospital stay.
